Lung Neoplasms: all 7,334 studies
Page 15 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RecruitingNCT04585750Phase 1/2
- Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54RecruitingNCT04577599Not applicable
- Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung CancerRecruitingNCT04542369Phase 2
- Ex-Vivo COF Study for Lung Cancer ObservationEnrolling by invitationNCT04534413
- Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLCRecruitingNCT04530708Not applicable
- Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLCRecruitingNCT04530227Phase 2
- A Multicenter Cancer Biospecimen Collection StudyRecruitingNCT04510129
- Develop and Test the Effects of the 'Computer-Assisted OPD COPSCCP on Early Stage Lung Cancer PatientsRecruitingNCT04506359Not applicable
- Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung CancerRecruitingNCT04499053Phase 2
- Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue InjuryRecruitingNCT04485286Phase 2
- Efficacy and Safety of CRT, Durvalumab and Surgery for SSTNot yet recruitingNCT04465968Phase 3
- A Prospective Cohort Study of Chinese Patients With Pulmonary Nodules: Prediction of Lung Cancer Using Noninvasive BiomarkersRecruitingNCT04462185
- Evaluation of IRDye800CW-nimotuzumab in Lung Cancer SurgeryRecruitingNCT04459065Phase 1/2
- Patient-Derived Xenografts to Reduce Cancer Health DisparitiesRecruitingNCT04410302
- Manchester Lung Health StudyRecruitingNCT04409444
- Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer (PLC) Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020RecruitingNCT04402099
- Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective StudyRecruitingNCT04401059Phase 4
- 'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)RecruitingNCT04375904Phase 2
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
- Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line RechallengeRecruitingNCT04335292Phase 2
- Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLCRecruitingNCT04324164
- Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLCRecruitingNCT04324151
- Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLCRecruitingNCT04324125
- Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic MutationRecruitingNCT04322890Phase 2
- Anlotinib Plus Immune Checkpoint Inhibitors for Lung CancerRecruitingNCT04322617Phase 2/3
- Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON TrialRecruitingNCT04322591
- Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLCRecruitingNCT04322578Phase 2
- A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLCRecruitingNCT04316364Phase 3
- Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung CancerRecruitingNCT04300062Not applicable
- Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityRecruitingNCT04273061Phase 2
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])RecruitingNCT04267848Phase 3
- A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) PatientsRecruitingNCT04237805Phase 1/2
- LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS)RecruitingNCT04228237
- LAT for Oligoprogressive NSCLC Treated With First-line OSImertinibRecruitingNCT04216121
- RCT of Uniport VATS for Lung CancerRecruitingNCT04212481Not applicable
- Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer SurgeryRecruitingNCT04209218Not applicable
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)RecruitingNCT04198766Phase 1/2
- Ventilation Heterogeneity Prior to Lung ResectionEnrolling by invitationNCT04191174
- Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerRecruitingNCT04181060Phase 3
- Talazoparib and Thoracic RT for ES-SCLCRecruitingNCT04170946Phase 1
- PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung CancerRecruitingNCT04151940Not applicable
- Thoracic Specimen RegistryRecruitingNCT04118660
- Stereotactic Magnetic Resonance Guided Radiation TherapyRecruitingNCT04115254Not applicable
- RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II TrialRecruitingNCT04105270Phase 2
- Markerless Image Guidance Using Intrafraction Kilovoltage X-ray ImagingRecruitingNCT04086082Not applicable
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruitingNCT04075305
- I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After RadiotherapyRecruitingNCT04071418
- Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung CancerRecruitingNCT04067830Phase 2
- Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung CancerRecruitingNCT04063501
- Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)RecruitingNCT04040361Phase 2
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsRecruitingNCT04038619Phase 1
- VATS VS. Open Thoracic Surgery for Stage II - III Lung CancerRecruitingNCT04009915Phase 3
- Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.RecruitingNCT03992885Phase 3
- Patient-derived Organoids of Lung Cancer to Test Drug ResponseRecruitingNCT03979170
- Synapse 3D With Intravascular Indocyanine GreenRecruitingNCT03953144Phase 1/2
- Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversRecruitingNCT03948100Not applicable
- Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung CancerRecruitingNCT03908671Not applicable
- Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLCRecruitingNCT03872661Phase 2
- Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)RecruitingNCT03848052
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerRecruitingNCT03819296Phase 1
- Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung CancerNot yet recruitingNCT03807102Phase 1/2
- Cell Free DNA for the Diagnosis and Treatment in Early NSCLCRecruitingNCT03791034
- TCR-T Cell Immunotherapy of Lung Cancer and Other Solid TumorsRecruitingNCT03778814Phase 1
- Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsRecruitingNCT03755739Phase 2/3
- Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLCRecruitingNCT03742687Not applicable
- Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsRecruitingNCT03740256Phase 1
- Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer PatientsEnrolling by invitationNCT03721133
- Study Comparing Two Different Schedules of Radiation for Early-stage Lung CancerRecruitingNCT03706027Not applicable
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
- Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung CancerRecruitingNCT03655015
- Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung CancerRecruitingNCT03647592
- Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung CancerRecruitingNCT03647111
- Survival Outcomes of Lung CancerRecruitingNCT03647098
- Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung CancerRecruitingNCT03646994
- Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save StudyRecruitingNCT03646968Phase 2
- PAlliative RAdioTherapy to Lung Cancer A Randomized Multicentre Phase III StudyRecruitingNCT03632603Phase 3
- Image Guided VATS vs. VATS ResectionRecruitingNCT03623958Not applicable
- Post-operative Urinary Retention (POUR) Following Thoracic SurgeryRecruitingNCT03609580Phase 1/2
- Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During SurgeryRecruitingNCT03582124Phase 1/2
- Genomic Analysis to Identify a Predictive Biomarker for ImmunotherapyRecruitingNCT03578185
- Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung CancerRecruitingNCT03563976
- Lung Cancer Screening in a Population Exposed to Occupational Lung CarcinogensRecruitingNCT03562052
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaRecruitingNCT03556228Phase 1/2
- Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis PatientsRecruitingNCT03535545Phase 1
- Clinical Study of Combined Radical Operation With Postoperative Adjuvant Chemotherapy and Prophylactic Cranial Irradiation in pT1-2N0M0 Stage of Small Cell Lung CancerRecruitingNCT03514849Not applicable
- Vapor Ablation for Localized Cancer LesionsNot yet recruitingNCT03514329Not applicable
- Microwave Ablation in Ground Glass NodulesNot yet recruitingNCT03490890Phase 2
- Collection of Sputum and Labeling for Lung CancerRecruitingNCT03457415
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung CancerRecruitingNCT03422302Not applicable
- A Clinico-biological Database of Lung CancersRecruitingNCT03387865
- Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFRNot yet recruitingNCT03381430Not applicable
- Adjuvant Chemotherapy for High Risk Stage I Lung AdenocarcinomaRecruitingNCT03380468Phase 2/3
- Antigen-specific T Cells Against Lung CancerNot yet recruitingNCT03356808Phase 1/2
- Dabrafenib and/or Trametinib Rollover StudyRecruitingNCT03340506Phase 4
- Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)RecruitingNCT03334864
- WTC Chest CT Imaging ArchiveEnrolling by invitationNCT03295279
- Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®RecruitingNCT03290534Phase 2
- A Prognosis and Predicting Genetic Study of Lung CancerNot yet recruitingNCT03234179
- GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against CancersRecruitingNCT03198052Phase 1